891417--3/2/2006--NANO_PROPRIETARY__INC

related topics
{product, candidate, development}
{property, intellectual, protect}
{product, market, service}
{customer, product, revenue}
{personnel, key, retain}
{system, service, information}
{cost, regulation, environmental}
{control, financial, internal}
{regulation, government, change}
{financial, litigation, operation}
{capital, credit, financial}
{acquisition, growth, future}
{gas, price, oil}
Our success is dependent on our principal technologies Products using our technology may not be accepted by the market Our technology development is in its early stages and the outcome is uncertain Our development partners have certain rights to jointly developed property and to license our technology We have limited resources and our focus on particular products may result in our failure to capitalize on other opportunities We may not be able to provide system integration Rapid technological changes could render our technology obsolete and we may not remain competitive We have limited manufacturing capacity and experience The health effects of nanotechnology are unknown The loss of key personnel could adversely affect our business We have a history of net losses We have no current royalty agreements producing significant revenue We are dependent on the availability of materials and suppliers Our revenues have been dependent on government contracts in the past We have technologies subject to licenses We may have future capital needs and the source of that funding is uncertain We may be unable to enforce or defend our ownership and use of proprietary technology We are exposed to litigation liability

Full 10-K form ▸

related documents
891417--3/9/2007--NANO_PROPRIETARY__INC
880432--9/28/2010--MISONIX_INC
64978--2/28/2007--MERCK_&_CO_INC
64978--2/27/2009--MERCK_&_CO_INC
32878--9/13/2006--ENERGY_CONVERSION_DEVICES_INC
849636--3/16/2006--CORTEX_PHARMACEUTICALS_INC/DE/
897075--3/17/2008--REPROS_THERAPEUTICS_INC.
1110803--2/26/2010--ILLUMINA_INC
880432--9/26/2008--MISONIX_INC
886530--3/17/2008--DATATRAK_INTERNATIONAL_INC
351012--8/11/2006--INTERMAGNETICS_GENERAL_CORP
32878--8/29/2007--ENERGY_CONVERSION_DEVICES_INC
1026650--3/10/2006--ERESEARCHTECHNOLOGY_INC_/DE/
886530--3/16/2009--DATATRAK_INTERNATIONAL_INC
64978--2/28/2008--MERCK_&_CO_INC
891288--3/30/2006--QUESTCOR_PHARMACEUTICALS_INC
878828--3/31/2009--WIRELESS_TELECOM_GROUP_INC
878828--4/15/2010--WIRELESS_TELECOM_GROUP_INC
886530--3/16/2007--DATATRAK_INTERNATIONAL_INC
881890--6/14/2010--ABAXIS_INC
1034682--9/29/2008--HERITAGE_WORLDWIDE_INC
927761--4/9/2008--MYMETICS_CORP
1001193--3/17/2008--TRANSMETA_CORP
897075--3/16/2009--REPROS_THERAPEUTICS_INC.
875045--2/21/2007--BIOGEN_IDEC_INC
1123361--3/14/2006--VIASYS_HEALTHCARE_INC
95574--3/13/2006--SUPERIOR_UNIFORM_GROUP_INC
1102934--11/27/2007--CABOT_MICROELECTRONICS_CORP
28626--9/13/2007--LIFECORE_BIOMEDICAL_INC
5768--6/13/2008--AMERICAN_SCIENCE_&_ENGINEERING_INC